For privately held companies, Isomorphic’s raise is the second-largest in biotech history, surpassed only by Altos Labs’ $3 billion debut in 2022.
Isomorphic Labs said Tuesday it had closed a $2.1 billion Series B round, cementing its bellwether role in using AI for drug discovery.
For privately …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Isomorphic Labs’ $2.1 Billion Fundraise Is The Biggest Bet Yet On AI Drug Discovery
Alphabet’s Isomorphic Labs raises $2.1bn in Series B funding
Isomorphic Labs lands $2.1BN investment
Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B
Cerebras raises $5.6 billion in year's largest IPO
Odyssey, on second try, snags $279M in an IPO
Cerebras raises $5.55bn in the biggest US tech IPO since Snowflake
Cerebras' monster IPO, Cisco's big quarter, and the AI factory's real impact - SiliconANGLE
Anthropic's $900 billion valuation would make it more valuable than OpenAI for the first time
Anthropic approaches $1 trillion valuation as revenue grows fivefold
